This site is intended for health professionals only

At the heart of general practice since 1960

Read the latest issue online

Gold, incentives and meh

Government told to restrict gabapentin and pregabalin availability

The prescription drugs gabapentin and pregabalin could soon be more tightly regulated in the UK, after Government advisors called for them to be classed as controlled drugs.

The plan – which would see gabapentin and pregabalin categorised as ‘Class C’ drugs and placed under schedule 3 prescribing regulations – would mean the drugs cannot be repeat dispensed and prescriptions will only be valid for one month.

The move comes after increasing concerns over recreational use of the drugs, particularly amongst the opioid abusing population, and a rise in deaths related to their misuse.

In a letter to Home Office ministers, Professor Les Iverson, chair of the Advisory Council on the Misuse of Drugs, noted that Office for National Statistics data on deaths related to drug poisoning had recorded a ‘significant increase in deaths from 2012 onwards’.

This included 38 deaths where pregabalin was mentioned on the death certificate and 26 where gabapentin was mentioned.

The letter added that ‘pregabalin and gabapentin present a risk of addiction and a potential for illegal diversion and medicinal misuse’ and recommended that both drugs ‘are controlled under the Misuse of Drugs Act 1971 as Class C substances, and scheduled under the Misuse of Drugs Regulations 2001 (as amended) as Schedule 3’.

It comes after NHS England and Public Health England issued advice to GPs and other prescribers urging caution with the drugs, particularly where a patient may have a history of drug misuse.

RCGP prescribing advisor Dr Martin Duerden, a GP in North Wales, said the move would mainly affect users, as it will become an offence to carry either drug unless they are obtained through prescription, but that GPs ‘may need to be more circumspect in terms of carefully checking for appropriate use, and not writing prescriptions for large quantities’.

Dr Andrew Green, chair of the GPC’s clinical and prescribing subcommittee, said he ‘would support the move’.

Dr Green said: ‘All GPs will recognise the problems described in the submission, pregabalin in particular has huge potential for abuse and dependency.’

However, Pfizer, which markets both gabapentin and pregabalin, said it ‘strongly disagreed’ with the plans, which it said was based on ‘potentially misleading information’ that could impact negatively on patients.

In a statement, the company said: ‘We strongly disagree with this and are extremely concerned about the negative impact this recommendation, if adopted, could have on many patients living with chronic neuropathic pain, generalised anxiety disorder and epilepsy.’

The statement added: ‘We are concerned that the advice contains a number of inaccuracies and some potentially misleading information, and is contrary to the totality of the safety data available for pregabalin and gabapentin.

‘Controlling the supply of these products across the whole UK, would be a disproportionate measure that would impact on patients and their quality of life, and could also result in additional economic and operational burden on an already strained healthcare system.’

Correction: This story was changed on 27 January 2016 to indicate that under schedule 3 regulations drugs cannot be repeat dispensed (not prescribed)

 

 

Readers' comments (15)

  • You've got to admire the cheek of Pfizer (aka The Dark Side). They moan to the point of going to court to restrict the availability of generic pregabalin, they frequently have shortages of their own products but then they have the temerity to bleat supposedly on behalf of patients who may be unable to get pregabalin if there are changes to its legal status! Incidentally the spell checker changed Pregabalin to "prefab alien" - a far better name don't you think?

    Unsuitable or offensive? Report this comment

  • in my area pregabalin is referred to as the 'dustbin drug' because all the heart sinks with unresponsive neurotic psychiatric symptoms and unmanageable pain are on it. The minute you see a patient is taking it you know what to expect.

    Unsuitable or offensive? Report this comment

  • Yay! More ways to make us spend more time prescribing. Doing printed scripts non eps always makes things safer..... Or maybe not!!!

    Unsuitable or offensive? Report this comment

  • AS a chronic pain patient on pregabalin this adds to hassle as the pharmacy cannot deliver CDs and I have to arrange for a friend to pick them up.
    Note to pharmacist who suggested patients should be referred to pain clinic- thanks I've already been seen at NHNN national pain service and two local ones.

    Unsuitable or offensive? Report this comment

  • @2.44pm Fenella
    I would discuss with your pharmacy re CDs. There is no good reason from a legal point of view that they cannot deliver controlled drugs and I would argue from an ethical point of view that it is often required. I.e. Patients in chronic, severe pain, terminally ill. I would always prefer to do deliveries to patients who genuinely struggle to get to the pharmacy rather than those who may use it got convenience.

    Unsuitable or offensive? Report this comment

View results 10 results per page20 results per page

Have your say